926
Participants
Start Date
September 17, 2001
Primary Completion Date
December 8, 2008
Study Completion Date
December 8, 2008
Cedars Sinai Medical Center, Los Angeles
UCLA Center For Vaccine Research, Torrance
National Institute of Allergy and Infectious Diseases (NIAID)
NIH